National Bank of Canada
LABU icon

National Bank of Canada’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

National Bank of Canada’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-64
Closed -$8.24K – 3079
2024
Q3 		$8.24K Buy
+64
New +$8.35K ﹤0.01% 2125

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

National Bank of Canada's LABU Position: Q4 2024 in Review

National Bank of Canada sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2024, closing a stake of 64 shares — an estimated $8.24K sold.

National Bank of Canada first reported a position in LABU in Q3 2024 and held it in 1 quarter. The position peaked at $8.24K in Q3 2024. 37 funds tracked by Wall St. Rank hold LABU as of Q4 2024.

  • National Bank of Canada reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2024 after selling out during the quarter.
  • National Bank of Canada sold 64 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2024, an estimated $8.24K.
  • National Bank of Canada first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2024 and held it in 1 quarter.
  • National Bank of Canada's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $8.24K in Q3 2024.
  • 37 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2024.

Based on National Bank of Canada's 13F filing for Q4 2024, filed 12 Feb 2025.